Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

Claiborne Johnston, S.; Amarenco, Pierre; W. Albers, Gregory; Denison, Hans; Donald Easton, J.; R. Evans, Scott; Held, Peter; Jonasson, Jenny; Minematsu, Kazuo; A. Molina, Carlos; Wang, Yongjun; Sing Wong, Ka

doi:10.1056/nejmoa1603060

Public

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

Published in New England Journal of Medicine • May 10, 2016

Authors:

S. Claiborne Johnston

Pierre Amarenco

Gregory W. Albers

Abstract

BACKGROUND: Ticagrelor may be a more effective antiplatelet therapy than aspirin for the prevention of recurrent stroke and cardiovascular events in patients with acute cerebral ischemia. METHODS: We conducted an international double-blind, controlled trial in 674 centers in 33 countries, in which 1...

Subject

Medicine

Ticagrelor

Aspirin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!